We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mgi Pharma (MM) | NASDAQ:MOGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
Minnesota
(State or Other Jurisdiction of Incorporation) |
0-10736
(Commission File Number) |
41-1364647
(IRS Employer Identification No.) |
o | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit No. | Description | |
4.1
|
Amendment No. 2 to Rights Agreement, effective as of December 20, 2007, between MGI PHARMA, INC. and Wells Fargo Bank, N.A. | |
|
||
99.1
|
Press Release of MGI PHARMA, INC., dated December 26, 2007. |
MGI PHARMA, INC.
Dated: December 27, 2007
By:
/s/ Eric P. Loukas
Eric P. Loukas
Executive Vice President, Chief Operating Officer,
General Counsel and Corporate Secretary
Exhibit No.
Description
Amendment No. 2 to Rights
Agreement, effective as of December 20, 2007, between MGI PHARMA,
INC. and Wells Fargo Bank, N.A.
Press Release of MGI PHARMA, INC., dated December 26, 2007.
1 Year Mgi Pharma (MM) Chart |
1 Month Mgi Pharma (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions